P62. Semi-quantitative gene expression profiling for therapy prediction in a breast cancer neoadjuvant therapy study applying docetaxel/epirubicin/cyclophosphamide (TEC)

DC ElementWertSprache
dc.contributor.authorVogt, Ulrich
dc.contributor.authorSchlotter, C. M.
dc.contributor.authorBosse, U.
dc.contributor.authorBonk, Ulrich
dc.contributor.authorBrandt, Burkhard
dc.date.accessioned2023-07-11T11:28:24Z-
dc.date.available2023-07-11T11:28:24Z-
dc.date.issued2006
dc.identifier.urihttp://osnascholar.ub.uni-osnabrueck.de/handle/unios/70327-
dc.subjectMedicine
dc.subjectNeoadjuvant therapy
dc.subjectCyclophosphamide
dc.subjectChemotherapy
dc.subjectInternal medicine
dc.subjectDocetaxel
dc.subjectOncology
dc.subjectBreast cancer
dc.subjectEpirubicin
dc.subjectCancer
dc.titleP62. Semi-quantitative gene expression profiling for therapy prediction in a breast cancer neoadjuvant therapy study applying docetaxel/epirubicin/cyclophosphamide (TEC)
dc.typejournal article
dc.identifier.doihttps://doi.org/10.1016/j.ejcsup.2006.04.122
dc.description.volume4
dc.description.issue6
dc.description.startpage49
dc.description.endpage50
dc.identifier.externalhttps://openalex.org/W2063775184
dcterms.oaStatustrue
local.import.sourcefileopenalex_20230710.ris
local.rawaffiliationnull
Zur Kurzanzeige

Seitenaufrufe

1
Letzte Woche
1
Letzter Monat
1
geprüft am 09.06.2024

Google ScholarTM

Prüfen

Altmetric